A Single Center Prospective Study of Diagnostic Efficiency of 68Ga-PSMA PET in the Patients With Locally Advanced and Advanced Renal Cell Carcinoma
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The primary research purpose is to evaluate the diagnostic efficacy of 68Ga-PSMA PET in metastatic lesions of locally advanced and advanced renal cell carcinoma, and to compare with that of enhanced CT. The second purpose is to evaluate whether 68Ga-PSMA PET can change the treatment decision of patients with locally advanced and advanced renal cell carcinoma
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: f
View:
• 2017 AJCC renal cell carcinoma TNM stage III, IV lesions;
• In contrast-enhanced CT staging, suspicious metastases were found;
• There were no known peripheral or central venous problems;
• 68Ga PSMA PET / CT imaging can be performed within 6 weeks after the diagnosis of renal cell carcinoma;
• Signed the informed consent form of voluntary participation in clinical trials.
Locations
Other Locations
China
Xijing Hospital
RECRUITING
Xi'an
Time Frame
Start Date: 2021-06-01
Estimated Completion Date: 2025-06-01
Participants
Target number of participants: 300
Treatments
Experimental: PSMA PET Arm
The PSMA PET arm received PSMA PET and enhanced CT at the same time in the diagnosis of the patients with suspected renal cancer.
Related Therapeutic Areas
Sponsors
Leads: Xijing Hospital